Reproducibility of bone mineral density measurement in daily practice
Open Access
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (3) , 285-289
- https://doi.org/10.1136/ard.2002.005678
Abstract
Background: Bone mineral density (BMD) measurements are frequently performed repeatedly for each patient. Subsequent BMD measurements allow reproducibility to be assessed. Objective: To examine the reproducibility of BMD by dual energy x ray absorptiometry (DXA) and to investigate the practical value of different measures of reproducibility in a group of postmenopausal women. Methods: Ninety five women, mean age 59.9 years, underwent two subsequent BMD measurements of spine and hip. Reproducibility was expressed as smallest detectable difference (SDD), coefficient of variation (CV), and intraclass correlation coefficient (ICC). Sources of variation were investigated by multilevel analysis. Results: The median interval between measurements was 0 days (range 0–45). The mean difference (SD) between the measurements (g/cm2) was −0.001 (0.02) and −0.0004 (0.02) at L1-4 and the total hip, respectively. At L1-4 and the total hip, SDD (g/cm2) was ±0.05 and ±0.04 and CV (%) was 1.92 and 1.59, respectively. The ICC at spine and hip was 0.99. Conclusions: Reproducibility in the postmenopausal women studied was good. In a repeated DXA scan a BMD change exceeding 2√2CV (%), the least significant change (LSC), or the SDD should be regarded as significant. Use of the SDD is preferable to use of the CV and LSC (%) because of its independence from BMD and its expression in absolute units. Expressed as SDD, a BMD change of at least ±0.05 g/cm2 at L1-4 and ±0.04 g/cm2 at the total hip should be considered significant.Keywords
This publication has 31 references indexed in Scilit:
- Pubertal Maturation Characteristics and the Rate of Bone Mass Development Longitudinally Toward MenarcheJournal of Bone and Mineral Research, 2001
- Bone densitometry and the diagnosis of osteoporosisSeminars in Nuclear Medicine, 2001
- Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium AloneJournal of Bone and Mineral Research, 2001
- Ultrasound assessment of the endometrium in healthy, asymptomatic early post‐menopausal women: saline infusion sonohysterography versus transvaginal ultrasoundUltrasound in Obstetrics & Gynecology, 2000
- Bone Structure in Patients with Low Bone Mineral Density With or Without Vertebral FracturesJournal of Bone and Mineral Research, 2000
- Assessment of Significant Change in BMD: A New ApproachJournal of Bone and Mineral Research, 2000
- Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group studyArthritis & Rheumatism, 1999
- Interim Report and Recommendations of the World Health Organization Task-Force for OsteoporosisOsteoporosis International, 1999
- Individual Smallest Detectable Difference in Bone Mineral Density MeasurementsJournal of Bone and Mineral Research, 1999
- Should Perimenopausal Women Be Screened for Osteoporosis?Annals of Internal Medicine, 1986